50 CHEMICALS KNOWLEDGE HUB Issue 2 / October 2025 ROUNDTABLE How have you seen the global pharma market evolve over the past 12 months and what trends are you most closely watching? PV. Over the past 12 months, we’ve seen a clear shift toward innovation in biopharma and advanced therapies, alongside mounting pressure around cost containment. Macroeconomic factors, supply chain disruptions and the growing emphasis on regional manufacturing capacity have all shaped the market. At the same time, digitalisation, AI and data-driven decision-making are being adopted faster across R&D and clinical settings. The trends I’m most closely watching are the acceleration of personalised medicine, sustainability in manufacturing and the impact of regulatory changes around data and product transparency. PIETER VERCRUYSSE Director Customer Success Tjoapack A group of executives attended a roundtable discussion before CPHI Worldwide in Frankfurt. They were: Pieter Vercruysse (PV), Director Customer Success, Tjoapack; Michael Leuck (ML), Vice-President, Hongene Biotech; Bartłomiej Czubek (BC), Director of Business Development, Mabion; Martin Meeson (MM), CEO, Axplora; Eric Kaneps (EK), Vice-President, Sales & Marketing, Renaissance Lakewood; and Lisa Stasi (LS), VP & GM Global Pharma Strategy & EU Region Ecolab Life Sciences.
RkJQdWJsaXNoZXIy MjY2OTA4MA==